View Rule

View EO 12866 Meetings Printer-Friendly Version     Download RIN Data in XML
DOD/DODOASHA RIN: 0720-AB83 Publication ID: Spring 2021 
Title: TRICARE Coverage of National Institute of Allergy and Infectious Disease Coronavirus Disease 2019 Clinical Trials 
Abstract:

The Assistant Secretary of Defense for Health Affairs issued an interim final rule (IFR) with request for comments to temporarily amend the TRICARE regulation at 32 CFR part 199 by adding coverage for National Institute of Allergy and Infectious Disease-sponsored clinical trials for the treatment or prevention of coronavirus disease 2019 (COVID-19). This action is finalizing the interim final rule.

 

 
Agency: Department of Defense(DOD)  Priority: Other Significant 
RIN Status: Previously published in the Unified Agenda Agenda Stage of Rulemaking: Final Rule Stage 
Major: No  Unfunded Mandates: No 
CFR Citation: 32 CFR 199   
Legal Authority: 5 U.S.C. 301    10 U.S.C. ch 55   
Legal Deadline:  None
Timetable:
Action Date FR Cite
Interim Final Rule  10/30/2020  85 FR 68753   
Interim Final Rule Effective  10/30/2020 
Interim Final Rule Comment Period End  11/30/2020 
Final Action  09/00/2021 
Regulatory Flexibility Analysis Required: Undetermined  Government Levels Affected: Undetermined 
Federalism: No 
Included in the Regulatory Plan: No 
RIN Data Printed in the FR: No 
Agency Contact:
Erica Ferron
Defense Health Agency, Medical Benefits and Reimbursement Division
Department of Defense
Office of Assistant Secretary for Health Affairs
16401 E Centretech Parkway,
Aurora, CO 80011-9066
Phone:303 676-3626
Email: erica.c.ferron.civ@health.mil